Inventor · disambiguated record
Bei Shan
Also filed as: SHAN BEI
38 granted patents·16 pending applications·714 citations·filing 1993–2020
98Inventor score
Top patents by PatentIndex Score
54 records- 0199US8030457B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2008·Granted Oct 4, 2011·175 cites·27 claims
- 0298US8168762B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)JACKSON SIMON MARK·Filed 2011·Granted May 1, 2012·101 cites·22 claims
- 0397US9056915B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Jun 16, 2015·20 cites·23 claims
- 0497US9045547B2Methods of using antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)JACKSON SIMON MARK·Filed 2011·Granted Jun 2, 2015·42 cites·66 claims
- 0597US8981064B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Mar 17, 2015·20 cites·29 claims
- 0695US6316503B1LXR modulatorsTULARIK INC·Filed 2000·Granted Nov 13, 2001·100 cites·47 claims
- 0793US6777446B2FXR modulatorsTULARIK INC·Filed 2001·Granted Aug 17, 2004·47 cites·12 claims
- 0892US9920134B2Monoclonal antibodies to proprotein convertase subtilisin kexin type 9 (PCSK9)JACKSON SIMON MARK·Filed 2011·Granted Mar 20, 2018·13 cites·17 claims
- 0985US9493576B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Nov 15, 2016·2 cites·43 claims
- 1084US6316484B1Pentafluorobenzenesulfonamides and analogsTULARIK INC·Filed 2000·Granted Nov 13, 2001·13 cites·14 claims
- 1182US10752664B2Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (GDF-15)XIONG YUMEI·Filed 2012·Granted Aug 25, 2020·4 cites·11 claims
- 1282US7033810B2Sitosterolemia susceptibility gene (SSG): compositions and methods of useAMGEN INC·Filed 2001·Granted Apr 25, 2006·6 cites·19 claims
- 1382US6388131B2Benzene compounds as antiproliferative and cholesterol lowering agentsTULARIK INC·Filed 2001·Granted May 14, 2002·10 cites·27 claims
- 1481US6465258B1FXR receptor-mediated modulation cholesterol metabolismTULARIK INC·Filed 2000·Granted Oct 15, 2002·26 cites·47 claims
- 1579US6906069B1LXR modulatorsAMGEN INC·Filed 2000·Granted Jun 14, 2005·18 cites·24 claims
- 1674US6962929B2Pentafluorobenzenesulfonamides and analogsTULARIK INC·Filed 2002·Granted Nov 8, 2005·6 cites·20 claims
- 1774US6821750B2ABCG8 vectors, host cells, and method of makingTULARIK INC·Filed 2001·Granted Nov 23, 2004·3 cites·35 claims
- 1874US5880151APentafluorobenzenesulfonamides and analogsTULARIK INC·Filed 1997·Granted Mar 9, 1999·25 cites·67 claims
- 1971US2015087819A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)AMGEN INC·Filed 2014·Application pending·0 cites
- 2070US6297019B1Recombinant polynucleotides encoding CYP7 promoter-binding factorsTULARIK INC·Filed 2000·Granted Oct 2, 2001·1 cites·20 claims
- 2170US6284923B1Substituted benzene compounds as antiproliferative and cholesterol lowering actionTULARIK INC·Filed 1997·Granted Sep 4, 2001·24 cites·16 claims
- 2268US7138418B2Pentafluorobenzenesulfonamides and analogsAMGEN INC·Filed 2001·Granted Nov 21, 2006·2 cites·28 claims
- 2366US2013058944A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)AMGEN INC·Filed 2012·Application pending·0 cites
- 2466US2013079502A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)AMGEN INC·Filed 2012·Application pending·0 cites
- 2565US8426358B2Methods for treating atherosclerosisKAYSER FRANK·Filed 2011·Granted Apr 23, 2013·1 cites·6 claims
- 2665US7662376B2Sitosterolemia susceptibility gene (SSG): compositions and methods of useAMGEN INC·Filed 2006·Granted Feb 16, 2010·0 cites·8 claims
- 2765US2013079501A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)JACKSON SIMON MARK·Filed 2012·Application pending·0 cites
- 2865US2012213797A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)JACKSON SIMON MARK·Filed 2012·Application pending·0 cites
- 2965US2013052201A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)AMGEN INC·Filed 2012·Application pending·0 cites
- 3065US2012251544A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)JACKSON SIMON MARK·Filed 2012·Application pending·0 cites
- 3165US2013085265A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)JACKSON SIMON MARK·Filed 2012·Application pending·0 cites
- 3262US6121304APentafluorobenzenesulfonamides and analogsTULARIK INC·Filed 1999·Granted Sep 19, 2000·12 cites·10 claims
- 3362US2011027287A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)AMGEN INC·Filed 2010·Application pending·0 cites
- 3461US6482860B1Pentafluorobenzenesulfonamides and analogsTULARIK INC·Filed 1997·Granted Nov 19, 2002·14 cites·17 claims
- 3560US2020325200A1Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15)AMGEN INC·Filed 2020·Application pending·0 cites
- 3659US7229816B2Sitosterolemia susceptibility gene (SSG) polypeptidesAMGEN INC·Filed 2005·Granted Jun 12, 2007·0 cites·13 claims
- 3758US2008096900A1Methods for treating atherosclerosisAMGEN INC·Filed 2007·Application pending·0 cites
- 3857US9006408B2Modified lecithin-cholesterol acyltransferase enzymesAMGEN INC·Filed 2014·Granted Apr 14, 2015·0 cites·16 claims
- 3957US8257934B2Screening methods using sitosterolemia susceptibility gene (SSG) polypeptidesTIAN HUI·Filed 2010·Granted Sep 4, 2012·0 cites·8 claims
- 4055US7105313B2Cell-based drug screens for regulators of gene expressionAMGEN INC·Filed 2003·Granted Sep 12, 2006·1 cites·21 claims
- 4154US8168416B2Modified lecithin-cholesterol acyltransferase enzymesBOONE TOM·Filed 2008·Granted May 1, 2012·0 cites·69 claims
- 4254US6566089B1Cell-based drug screens for regulators of gene expressionTULARIK INC·Filed 1997·Granted May 20, 2003·9 cites·13 claims
- 4354US2013273024A1Methods for treating atherosclerosisAMGEN INC·Filed 2013·Application pending·0 cites
- 4448US7511043B2FXR modulatorsAMGEN INC·Filed 2004·Granted Mar 31, 2009·0 cites·8 claims
- 4547US2002119958A1Therapeutic agent for hyperlipidemiaFiled 2001·Application pending·0 cites
- 4646US8703926B1Modified lecithin-cholesterol acyltransferase enzymesZHOU MINGYUE·Filed 2012·Granted Apr 22, 2014·0 cites·48 claims
- 4744US5958697AIsolated nucleic acids encoding CYP7 promoter-binding factorsTULARIK INC·Filed 1998·Granted Sep 28, 1999·2 cites·5 claims
- 4844US2002048572A1Treatment of hypertriglyceridemia and other conditions using LXR modulatorsFiled 2001·Application pending·0 cites
- 4942US2013072665A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)JACKSON SIMON MARK·Filed 2012·Application pending·0 cites
- 5041US6555326B1Nuclear hormone receptor fluorescence polarization assayTULARIK INC·Filed 1997·Granted Apr 29, 2003·8 cites·18 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →